Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events
- PMID: 7897410
- PMCID: PMC1073365
- DOI: 10.1136/jnnp.58.3.300
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events
Abstract
The clinical data of 309 patients with definite multiple sclerosis were recorded in the European data base for multiple sclerosis (EDMUS) to determine the prognostic significance of several demographic and clinical variables. An interview with closed questions structured according to standardised criteria of disease phases and courses was used to assess the clinical course. The reliability was evaluated by four trained neurologists in a sample of 33 patients with multiple sclerosis. Both the within and between rater agreement on data collection was fair to high for the historical variables (K = 0.33-1). Between rater agreement was more variable for the evaluation of 12 different EDMUS event categories (K = 0.3-0.95). The predictive model for the time to reach a secondary progression showed that an age at onset older than 25 (p = 0.006) and an event at onset followed by disability > or = 3 on the Kurtzke expanded disability status scale (EDSS; p = 0.004) were the most unfavourable clinical variables in 249 patients with relapsing remitting (180) or relapsing progressive (69) courses. In the 69 patients with relapsing progressive disease, the time to reach severe disability (EDSS > or = 6) was negatively influenced by a first interval between attacks shorter than one year, a number of bouts with EDSS > 2 in the first two years of the disease, and involvement of the pyramidal system at onset (p < 0.05). In 60 patients with chronic progressive disease this outcome was negatively influenced by pyramidal, brainstem, and sensory involvement at onset (p < 0.01).
Similar articles
-
European validation of a standardized clinical description of multiple sclerosis.J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0. J Neurol. 2004. PMID: 15645346
-
Prognostic factors for survival in multiple sclerosis.Mult Scler. 1999 Jun;5(3):171-8. doi: 10.1177/135245859900500306. Mult Scler. 1999. PMID: 10408717
-
Natural history of multiple sclerosis: a unifying concept.Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16. Brain. 2006. PMID: 16415308
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
-
The prognostic value of age, gender, pregnancy and endocrine factors in multiple sclerosis.Neurol Sci. 2000;21(4 Suppl 2):S857-60. doi: 10.1007/s100720070026. Neurol Sci. 2000. PMID: 11205363 Review.
Cited by
-
European validation of a standardized clinical description of multiple sclerosis.J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0. J Neurol. 2004. PMID: 15645346
-
Predictive factors and treatment challenges in malignant progression of relapsing-remitting multiple sclerosis.Heliyon. 2024 Feb 17;10(4):e26658. doi: 10.1016/j.heliyon.2024.e26658. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38420491 Free PMC article.
-
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):382-7. doi: 10.1136/jnnp.60.4.382. J Neurol Neurosurg Psychiatry. 1996. PMID: 8774400 Free PMC article.
-
Systematic review of prediction models in relapsing remitting multiple sclerosis.PLoS One. 2020 May 26;15(5):e0233575. doi: 10.1371/journal.pone.0233575. eCollection 2020. PLoS One. 2020. PMID: 32453803 Free PMC article.
-
Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities.J Neurol. 2007 Feb;254(2):220-7. doi: 10.1007/s00415-006-0334-5. Epub 2007 Feb 17. J Neurol. 2007. PMID: 17308868
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical